Central Diagnostic Laboratory and Research Centre Pvt. Ltd, Kathmandu, Nepal.
International Vaccine Institute, Seoul, Republic of Korea.
Ann Clin Microbiol Antimicrob. 2018 Jul 16;17(1):32. doi: 10.1186/s12941-018-0284-7.
The introduction of the dengue virus (DENV) in Nepal is recent, first reports date back to 2004 from a Japanese traveller and limited information is available about DENV infection in the Nepali population. Within a decade after the first DENV detection, it is now endemic in multiple districts of Nepal with approximately 11.2 million people residing in the Terai belt being at risk of DENV infection. Sporadic cases of DENV infection have been reported every year for the past decade during the monsoon season, mainly in the Terai region.
Medline/Embase/Cochrane databases were reviewed for reports on the burden of dengue infection, diagnostic methods, and national surveillance.
Four outbreaks were reported since 2004 including the diagnosis of all serotypes in 2006 and predominance of a single serotype in 2010 (DENV-1), 2013 (DENV-2), and 2016 (DENV-1). The clinical diagnoses showed a predominance of dengue fever while 4/917 (0.4%), 8/642 (1.2%) and 8/1615 (0.4%) dengue haemorrhagic fever/dengue shock syndrome cases were identified during the outbreaks in 2010, 2013 and 2016, respectively. The number of cases reported in males was significantly higher (67.4%) than in females. Disease occurrence was primarily found in the Terai region until 2010 and was increasingly detected in the Hilly region in 2016.
In Nepal currently weak diagnostic facilities, very limited research on mosquitoes vectors, and poor surveillance of dengue leading to inappropriate detection and control of DENV. We surmise that improved basic research and epidemiological training courses for local scientists and laboratory personal at national and international level will help better understand the evolution and distribution of DENV transmission and its eventual control.
登革热病毒(DENV)在尼泊尔的引入时间较晚,首次报告可追溯至 2004 年,来自一名日本旅行者,有关尼泊尔人群中 DENV 感染的信息有限。在首次检测到 DENV 后的十年内,尼泊尔多个地区现已出现地方性流行,约 1120 万人居住在特莱地区,面临 DENV 感染的风险。在过去十年的季风季节中,每年都会报告零星的 DENV 感染病例,主要发生在特莱地区。
对 Medline/Embase/Cochrane 数据库进行了检索,以获取有关登革热感染负担、诊断方法和国家监测的报告。
自 2004 年以来报告了四起疫情,包括 2006 年所有血清型的诊断和 2010 年(DENV-1)、2013 年(DENV-2)和 2016 年(DENV-1)单一血清型的流行。临床诊断显示登革热占主导地位,而在 2010 年、2013 年和 2016 年的疫情中,分别有 4/917(0.4%)、8/642(1.2%)和 8/1615(0.4%)例登革出血热/登革休克综合征病例被确诊。报告的病例中男性明显多于女性(67.4%)。疾病发生主要集中在特莱地区,直到 2010 年才在丘陵地区发现,并于 2016 年在丘陵地区发现。
目前尼泊尔的诊断设施薄弱,对蚊子传播媒介的研究非常有限,对登革热的监测也不完善,导致对 DENV 的检测和控制不恰当。我们推测,加强基础研究和为国家和国际层面的当地科学家和实验室人员提供流行病学培训课程,将有助于更好地了解 DENV 传播的演变和分布及其最终控制。